[Federal Register Volume 66, Number 246 (Friday, December 21, 2001)]
[Notices]
[Pages 65992-65993]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-31409]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 11, 2001, Genesis 
1:29 Corporation, P.O. Box 2175, 133 Bond Avenue, Petaluma, California 
94654, made application to the Drug Enforcement Administration (DEA) 
for registration as a bulk manufacturer of the basis classes of 
controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)............................  I
Tetrahydrocannabinols (7370)................  I
------------------------------------------------------------------------

    The firm plans to cultivate marihuana to supply physician's 
patients within the State of California.

[[Page 65993]]

    This Notice of Application is being published as required pursuant 
to section 1301.33(a) of Title 21 CFR and does not authorize the 
applicant to manufacturer, distribute or possess any controlled 
substance.
    Since Marihuana is a Schedule I controlled substance identified in 
section 1308.11(d) of Title 21 CFR and has no legitimate medical use, 
the DEA intends to take all appropriate measures necessary to comply 
with domestic and international treaty obligations.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than February 19, 2002.

    Dated: December 13, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-31409 Filed 12-20-01; 8:45 am]
BILLING CODE 4410-09-M